Metraipolis › archive › dc_2b9814ebb391

Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials — Europe PMC PMID:42346261

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346261
DOI
10.3390/curroncol33060361
License (as archived)
solo-consultazione
Archived
2026-10-19T09:38:59.217Z
SHA-256 of the archived text
99158a2f14cdfd8d9e9fada1a688ccd77639c4751d39a7293c4cf99a00b118e2
Stable URL of this page
https://metraipolis.com/documento/dc_2b9814ebb391

How to cite

Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials — Europe PMC PMID:42346261 — Europe PMC (en), https://europepmc.org/article/MED/42346261 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b9814ebb391 (Metraipolis archive dc_2b9814ebb391, sha256 99158a2f14cdfd8d9e9fada1a688ccd77639c4751d39a7293c4cf99a00b118e2)
BibTeX
@misc{dc2b9814ebb391,
  title = {Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials — Europe PMC PMID:42346261},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346261},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b9814ebb391; sha256 99158a2f14cdfd8d9e9fada1a688ccd77639c4751d39a7293c4cf99a00b118e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346261. Agents can read the archived copy with the MCP tool read_document.